The 2025 Guideline Update Endorses Ticagrelor Monotherapy After ≥1 Month of DAPT Post-PCI in Patients With ACS: Is the Evidence Conclusive?
Department of Cardiology, Cedars-Sinai Medical Center, Los Angeles, California, USA ∗Address for correspondence: Dr Sanjay Kaul, Department of Cardiology, Cedars-Sinai Medical Center, 8635 West Third Street, Suite 485W, Los Angeles, California 90048, USA. E-mail: E-mail Address: [email protected] Department of Medicine and Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, Quebec, Canada Identifying strategies to mitigate bleeding risk with dual antiplatelet therapy (DAPT)
